Suppr超能文献

丙二酰辅酶 A-酰基载体蛋白转酰基酶的新设计平台。

New design platform for malonyl-CoA-acyl carrier protein transacylase.

机构信息

Korea Institute of Science and Technology, Life Sciences Division, Seoul, Republic of Korea.

出版信息

FEBS Lett. 2010 Mar 19;584(6):1240-4. doi: 10.1016/j.febslet.2010.02.038. Epub 2010 Feb 19.

Abstract

Malonyl-CoA-acyl carrier protein transacylase (MCAT) transfers the malonyl group from malonyl-CoA to holo-acyl carrier protein (ACP), and since malonyl-ACP is a key building block for fatty-acid biosynthesis it is considered as a promising antibacterial target. The crystal structures of MCAT from Staphylococcus aureus and Streptococcus pneumoniae have been determined at 1.46 and 2.1A resolution, respectively. In the SaMCAT structure, the N-terminal expression peptide of a neighboring molecule running in the opposite direction of malonyl-CoA makes extensive interactions with the highly conserved "Gly-Gln-Gly-Ser-Gln" stretch, suggesting a new design platform. Mutagenesis results suggest that Ser91 and His199 are the catalytic dyad.

摘要

丙二酰辅酶 A-酰基载体蛋白转酰基酶 (MCAT) 将丙二酰基从丙二酰辅酶 A 转移到酰基载体蛋白 (ACP) 上,由于丙二酰-ACP 是脂肪酸生物合成的关键构建块,因此它被认为是一种有前途的抗菌靶标。金黄色葡萄球菌和肺炎链球菌的 MCAT 的晶体结构已分别在 1.46 和 2.1A 分辨率下确定。在 SaMCAT 结构中,来自相反方向的相邻分子的 N 端表达肽与高度保守的“Gly-Gln-Gly-Ser-Gln”延伸段进行广泛相互作用,这表明了一个新的设计平台。突变结果表明 Ser91 和 His199 是催化二联体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验